Tortoise Investment Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-301
Closed -$22.1K 741
2025
Q3
$22.1K Buy
301
+1
+0.3% +$66 ﹤0.01% 504
2025
Q2
$15.6K Hold
300
﹤0.01% 552
2025
Q1
$19.1K Hold
300
﹤0.01% 509
2024
Q4
$14.3K Hold
300
﹤0.01% 589
2024
Q3
$17.2K Hold
300
﹤0.01% 574
2024
Q2
$15.7K Hold
300
﹤0.01% 570
2024
Q1
$12.2K Hold
300
﹤0.01% 599
2023
Q4
$11.1K Hold
300
﹤0.01% 556
2023
Q3
$11.5K Hold
300
﹤0.01% 537
2023
Q2
$10.8K Buy
+300
New +$10.2K ﹤0.01% 545

Other funds holding HALO

Tortoise Investment Management's HALO Position: Q4 2025 in Review

Tortoise Investment Management sold out of Halozyme (HALO) in Q4 2025, closing a stake of 301 shares — an estimated $22.1K sold.

Tortoise Investment Management first reported a position in HALO in Q2 2023 and held it in 10 quarters. The position peaked at $22.1K in Q3 2025. 618 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • Tortoise Investment Management reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
  • Tortoise Investment Management sold 301 Halozyme shares in Q4 2025, an estimated $22.1K.
  • Tortoise Investment Management first reported a position in Halozyme in Q2 2023 and held it in 10 quarters.
  • Tortoise Investment Management's Halozyme position peaked at $22.1K in Q3 2025.
  • 618 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Tortoise Investment Management's 13F filing for Q4 2025, filed 6 Feb 2026.